5 Stocks With Ugly Earnings Growth — CPHD BBRY HSGX GIGA GSOL

This week, these five stocks have the worst ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

Cepheid (CPHD) is a molecular diagnostics company that engages in developing, manufacturing, and marketing integrated systems for testing in the clinical market, as well as for application in legacy biothreat, industrial, and partner markets. The company also gets F’s in earnings growth. For more information, get Portfolio Grader’s complete analysis of CPHD stock.

BlackBerry Limited (BBRY) engages in the design, manufacture and marketing of wireless solutions worldwide. The company also gets F’s in sales growth, earnings growth, and earnings momentum. For more information, get Portfolio Grader’s complete analysis of BBRY stock.

Histogenics Corp.. The company also gets F’s in earnings growth. For more information, get Portfolio Grader’s complete analysis of HSGX stock.

Giga-tronics Incorporated (GIGA) designs, manufactures, and markets a line of test and measurement equipment. The company also gets F’s in earnings growth. For more information, get Portfolio Grader’s complete analysis of GIGA stock.

Global Sources Ltd. (GSOL) operates as a business-to-business media company primarily in greater China. The company also gets F’s in sales growth and earnings growth. For more information, get Portfolio Grader’s complete analysis of GSOL stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2016/05/5-stocks-with-ugly-earnings-growth-cphd-bbry-hsgx-giga-gsol/.

©2021 InvestorPlace Media, LLC